Total Funding
59
26
Total FundingSeries B raised
Growth Score
-25 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2909
Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.
- Whit Bernard: Founder and CEOPast Role: Metsera, Co-Founder and Chief Operating Officer
- Peter Wijngaard: Chief Development Officer
Pfizer
About the Company
Metsera is a biotechnology company that develops and manufactures therapies. The company's focus is on nutrient-stimulated hormone therapies for obesity and related conditions. Its portfolio includes both injectable and oral therapeutic candidates.
